山东大学耳鼻喉眼学报 ›› 2014, Vol. 28 ›› Issue (6): 18-20.doi: 10.6040/j.issn.1673-3770.0.2014.070

• 论著 • 上一篇    下一篇

耳后药物注射治疗突发性聋32例

江朝勇, 蔡永明, 殷亚磊   

  1. 深圳市宝安区沙井人民医院耳鼻喉科, 广东 深圳 518104
  • 收稿日期:2014-02-26 发布日期:2014-12-16
  • 作者简介:江朝勇. E-mail:jiangchaoyongdc@163.com

Clinical trial of postaurical drug injection to treat sudden hearing loss

JIANG Chao-yong, CAI Yong-ming, YIN Ya-lei   

  1. Department of Otolaryngology, Shenzhen Bao'an District Shajing People's Hospital, Shenzhen 518104, Guangdong, China
  • Received:2014-02-26 Published:2014-12-16

摘要: 目的 观察耳后注射糖皮质激素治疗突发性聋的疗效.方法 65例突聋患者分为耳后注射组(32例)和鼓室给药组(33例),除常规治疗外,两组分别经耳后注射和鼓膜穿刺给予地塞米松0.5 mg,1次/3 d,疗程14 d.结果 耳后注射组和鼓室给药组听力改善分别为(13.2±8.6)dB和(14.6±11.1)dB,两组治疗前后比较差异均有统计学意义(P<0.05),组间比较差异无统计学意义(P>0.05),不良反应试验组低于对照组(P<0.05).结论 突聋患者耳后局部注射糖皮质激素效果明显、操作简单、不良反应低,可作为鼓室给药有禁忌时的备选疗法.

关键词: 突发性聋, 耳后注射, 地塞米松, 鼓膜注射

Abstract: Objective To evaluate the postaurical injection of corticosteroids to treat sudden hearing loss. Methods 65 patients with sudden hearing loss were divided into postaurical injection group (n=32) and intratympanic administration group (n=33). In addition to conventional medication, two groups were injected dexamethasone 0.5 mg through postaurical or intratympanic approaches on every three days in a 14-day course. Results The hearing improvement in postaurical injection group and intratympanic administration group were 13.2±8.6 dB and 14.6±11.1 dB. Compared to the pre-treatment, the differences were significant in both groups (P<0.05), however, no significant difference were noted between the groups (P>0.05). Adverse reactions occurred less in experimental group than the control (P<0.05). Conclusion Postaurical injection is effective, simple and safe to treat sudden hearing loss, which can serve as an alternative for intratympanic administration.

Key words: Sudden hearing loss, Postaurical injection, Intratympanic injection, Dexamethasone

中图分类号: 

  • R764.43
[1] Stachler R J, Chandrasekhar S S, Archer S M, et al. Clinical practice guideline: sudden hearing loss[J]. Otolaryngol Head Neck Surg, 2012, 146(3):1-35.
[2] 李昕琚,梁勇,蒋涛,等. 突发性聋临床实践指南[J]. 听力学及言语疾病杂志,2012,20(6):600-612. LI Xiju, LIANG Yong, JIANG Tao, et al. Clinical practice guidelines sudden deafness[J]. J Audiol Speech Pathol, 2012, 20(6):600-612.
[3] 杨晓琦,余力生,马鑫. 耳后注射复方倍他米松治疗顽固性低频型感音神经性聋[J]. 中华耳鼻咽喉头颈外科杂志,2007,42(11):814-816. YANG Xiaoqi, YU Lisheng, MA Xin. Injection of compound betamethasone in treatment of resistant type low frequency sensorineural deafness[J]. Chin J Otorhinolaryngol Head Neck Surgery, 2007, 42(11):814-816.
[4] 张运波,杨艺全,习国平,等. 乳突骨膜下注射甲泼尼龙琥珀酸钠治疗突发性聋[J]. 听力学及言语疾病杂志,2012,20(4):375-376. ZHANG Yunbo, YANG Yiquan, XI Guoping, et al. Mastoid subperiosteal armour prednisolone injection sodium succinate to treat sudden deafness[J]. J Audiol Speech Pathol, 2012, 20(4):375-376.
[5] Rauch S D, Halpin C F, Antonelli P J, et al. Oral vs intratympanic corticosteroid therapy for idiopathic sudden sensorineural hearing loss: a randomized trial[J]. JAMA, 2011, 305(20):2071-2079.
[6] 李晶兢,余力生,夏睿,等. 7.0T磁共振成像观察耳后给药促进药物进入内耳的可行性[J]. 中华耳科学杂志,2012,10(2):144-148 LI Jingjing, YU Lisheng, XIA Rui, et al. Feasibility study of inner ear drug delivery via post-auricular injection using 7.0 Tesla MRI[J]. Chin J Otol, 2012, 10(2):144-148.
[7] 黑任轶. 经耳后乳突部皮下注射途径靶向内耳给药的初步研究[D]. 西安:第四军医大学, 2008. HEI Renyi. Mastoid subcutaneous injections of targeted inner ear for preliminary study[D]. Xi'an: Fourth Military Medical University, 2008.
[8] 静媛媛,余力生,李兴启.耳后注射复方倍他米松豚鼠血浆中药代动力学特征[J].听力学及言语疾病杂志,2009,17(4):355-357. JING Yuanyuan, YU Lisheng, LI Xingqi. Compound betameth pharmacokinetics in plasma of guinea pig after postaurieal injection[J]. J Audiol Speech Pathol, 2009, 17(4):355-357.
[1] 许明,罗兴谷,唐洪波,江青山. 儿童突发性聋的临床特征及预后相关因素分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 41-44.
[2] 陈伟,胡中南,童钊君,李湘宇,刘文君. 青中年无眩晕、心脑血管疾病病史的突发性聋患者高刺激率听性脑干反应特征分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 45-49.
[3] 朱文燕,金新,佘万东,马永驰. 突发性聋30例精神心理状况分析[J]. 山东大学耳鼻喉眼学报, 2018, 32(5): 50-52.
[4] 黄颖铭,万保罗,靳钰炜. 复方倍他米松联合盐酸利多卡因辅助治疗突发性聋的疗效观察[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 11-13.
[5] 张玉波,岳丽艳,尹晓妍,吕哲,单春光. 耳鸣治疗仪联合银杏叶提取物注射液治疗突聋伴耳鸣的疗效分析[J]. 山东大学耳鼻喉眼学报, 2017, 31(5): 50-53.
[6] 朱江彬,南兵卫,陈涛, 郝宗生. 低中频下降型突发性聋听阈恢复后残留耳鸣治疗体会[J]. 山东大学耳鼻喉眼学报, 2016, 30(6): 5-7.
[7] 刘阳云,张彩霞,江文,陈琼,常恩格,赵花香,杨会. 突发性聋患者血脂分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(6): 1-4.
[8] 马荣峰,朱富高,孙美红,付涛,张晓恒,曹琳. 突发性聋预后的相关因素分析及疗程选择[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 69-74.
[9] 衡伟伟,后婕,魏先梅,佘万东. TNF-α和IL-8在突发性聋患者血清及外周血单个核细胞中的表达及其意义[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 40-45.
[10] 狄国华, 刘俊茹, 赵延祥, 高英恺. 利多卡因联合天麻素耳后注射治疗特发性耳鸣[J]. 山东大学耳鼻喉眼学报, 2015, 29(6): 5-7.
[11] 钟晓声, 杨海弟, 郑亿庆. 突发性聋伴耳鸣患者耳鸣特征[J]. 山东大学耳鼻喉眼学报, 2015, 29(4): 15-18.
[12] 卢娜. 三种不同给药途径治疗突发性感音神经性耳聋的效果对比[J]. 山东大学耳鼻喉眼学报, 2015, 29(2): 24-27.
[13] 张彩霞, 刘阳云, 陈志喜, 江文, 李正贤, 陈琼, 常恩格. 鼓室激素注射为初始治疗的突发性聋听力恢复的时间规律[J]. 山东大学耳鼻喉眼学报, 2015, 29(1): 15-18.
[14] 周慧, 黄雪琴, 胡俊丽, 姚俊, 张月飞, 江枫. 黄芩苷对鼻咽癌化疗期间激素使用影响的实验研究[J]. 山东大学耳鼻喉眼学报, 2014, 28(4): 30-32.
[15] 刘冬梅1,徐开伦1,罗晓1,贾全凡1,任贤灵1,袁龙1,罗通勇1,刘军2,马殿伟2, 岳胜清1,文晓蛟1,付誉颖2. 鼓室联合静脉地塞米松+传统方法治疗突发性耳聋的近期疗效[J]. 山东大学耳鼻喉眼学报, 2013, 27(1): 26-30.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!